Serum metabonomics characterization of liver fibrosis induced by bile duct-ligated in rats and the intervention effects of herb compound 861

References

• Anuja, G. I.; Shine, V. J.; Latha, P. G.; Suja, S. R. Protective Effect of Ethyl Acetate Fraction of Drynaria Quercifolia against CCl4 Induced Rat Liver Fibrosis via Nrf2/ARE and NFκB Signalling Pathway. J. Ethnopharmacol. 2018, 216, 79–88. DOI: 10.1016/j.jep.2017.11.015.
   PubMed Web of Science ®Google Scholar
• Bataller, R.; Brenner, D. A. Liver Fibrosis. J. Clin. Invest. 2005, 115, 209–218. DOI: 10.1172/JCI24282.
   PubMed Web of Science ®Google Scholar
• Dufour, J. F.; DeLellis, R.; Kaplan, M. M. Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis. Ann. Intern. Med. 1997, 127, 981–985. DOI: 10.7326/0003-4819-127-11-199712010-00006.
   PubMed Web of Science ®Google Scholar
• Ghosh, N.; Ghosh, R.; Mandal, V.; Mandal, S. C. Recent Advances in Herbal Medicine for Treatment of Liver Diseases. Pharm. Biol. 2011, 49, 970–988. DOI: 10.3109/13880209.2011.558515.
   PubMed Web of Science ®Google Scholar
• Chen, S. R.; Chen, X. P.; Lu, J. J.; Wang, Y.; Wang, Y. T. Potent Natural Products and Herbal Medicines for Treating Liver Fibrosis. Chin. Med 2015, 10, 7. DOI: 10.1186/s13020-015-0036-y.
   PubMed Web of Science ®Google Scholar
• Ghazwani, A.; Zhang, Y.; Gao, X.; Fan, J.; Li, J.; Li, S. Anti-fibrotic Effect of Thymoquinone on Hepatic Stellate Cells. Phytomedicine 2014, 21, 254–260. DOI: 10.1016/j.phymed.2013.09.014.
   PubMed Web of Science ®Google Scholar
• Wang, X. J.; Zhang, A. H.; Sun, H.; Han, Y.; Yan, G. L. Discovery and Development of Innovative Drug from Traditional Medicine by Integrated Chinmedomics Strategies in the Post-genomic Era. Trac. Trend Anal. Chem 2016, 76, 88–94. DOI: 10.1016/j.trac.2015.11.010.
   Web of Science ®Google Scholar
• Wang, L.; Wang, J.; Wang, B. E.; Xiao, P. G.; Qiao, Y. J.; Tan, X. H. Effects of Herbal Compound 861 on Human Hepatic Stellate Cell Proliferation and Activation. World J. Gastroenterol. 2004, 10, 2831–2835.
   PubMed Web of Science ®Google Scholar
• Wei, D.; Liao, S.; Wang, J.; Yang, M.; Kong, L. Cholestatic Liver Injury Model of Bile Duct Ligation and the Protection of Huang-Lian-Jie-Du Decoction by NMR Metabolomic Profiling. RSC Adv. 2015, 5, 66200–66211. DOI: 10.1039/C5RA12224D.
   Web of Science ®Google Scholar
• Dong, S.; Cai, F. F.; Chen, Q. L.; Song, Y. N.; Sun, Y.; Wei, B.; Li, X. Y.; Hu, Y. Y.; Liu, P.; S.B, S. Chinese Herbal Formula Fuzheng Huayu Alleviates CCl4-induced Liver Fibrosis in Rats: a Transcriptomic and Proteomic Analysis. Acta Pharmacol. Sin 2018, 39, 930–941. DOI: 10.1038/aps.2017.150.
   PubMed Web of Science ®Google Scholar
• Wang, L.; Wang, B. E.; Wang, J.; Xiao, P. G.; Tan, X. H. Herbal Compound 861 Regulates mRNA Expression of Collagen Synthesis- and Degradation Related Genes in Human Hepatic Stellate Cells. WJG. 2008, 14, 1790–1794. DOI: 10.3748/wjg.14.1790.
   PubMed Web of Science ®Google Scholar
• Yin, S. S.; Wang, B. E.; Wang, T. L.; Jia, J. D.; Qian, L. X. The Effect of Cpd 861 on Chronic Hepatitis B Related Fibrosis and Early Cirrhosis: A Randomized, Double Blind, Placebo Controlled Clinical Trial. Zhonghua Gan Zang Bing Za Zhi 2004, 12, 467–470.
   PubMedGoogle Scholar
• Hou, F.; Liu, R. X.; Liu, X. Y.; Cui, L. J.; Wen, Y.; Yan, S. B.; Yin, C. H. Attenuation of Liver Fibrosis by Herbal Compound 861 via Upregulation of BMP-7/Smad Signaling in the Bile Duct Ligation Model Rat. Mol. Med. Rep. 2016, 13, 4335–4342. DOI: 10.3892/mmr.2016.5071.
   PubMed Web of Science ®Google Scholar
• Chi, C.; Liu, X. Y.; Hou, F.; Yu, X. Z.; Li, C. Y.; Cui, L. J.; Liu, R. X.; Yin, C. H. Herbal Compound 861 Prevents Hepatic Fibrosis by Inhibiting the TGF-β1/Smad/SnoN Pathway in Bile Duct-ligated Rats. BMC Complem. Altern. M. 2018, 18, DOI: 10.1186/s12906-018-2119-7.
   PubMed Web of Science ®Google Scholar
• Forestier, M.; Solioz, M.; Isbeki, F.; Talos, C.; Reichen, J.; Krahenbuhl, S. Hepatic Mitochondrial Proliferati Corson on in Rats with Secondary Biliary Cirrhosis: Time Course and Mechanisms. Hepatology. 1997, 26, 386–391. DOI: 10.1002/hep.510260219.
   PubMed Web of Science ®Google Scholar
• Wang, M.; Lamers, R.-J. A. N.; Korthout, H. A. A. J.; van Nesselrooij, J. H. J.; Witkamp, R. F.; van der Heijden, R.; Voshol, P. J.; Havekes, L. M.; Verpoorte, R.; van der Greef, J. Metabolomics in the Context of Systems Biology: Bridging Traditional Chinese Medicine and Molecular Pharmacology. Phytother. Res. 2005, 19, 173–182. DOI: 10.1002/ptr.1624.
   PubMed Web of Science ®Google Scholar
• Zhang, A.; Sun, H.; Wang, Z.; Sun, W.; Wang, P.; Wang, X. Metabolomics: Towards Understanding Traditional Chinese Medicine. Planta Med. 2010, 76, 2026–2035. DOI: 10.1055/s-0030-1250542.
   PubMed Web of Science ®Google Scholar
• Nicholson, J.; Lindon, J.; Holmes, E. Metabonomics: Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli via Multivariate Statistical Analysis of Biological NMR Spectroscopic Data. Xenobiotica. 1999, 29, 1181–1189. DOI: 10.1080/004982599238047.
   PubMed Web of Science ®Google Scholar
• Liu, X. J.; Zhou, Y. Z.; Li, Z. F.; Cui, J.; Li, Z. Y.; Gao, X. X.; Sun, H. F.; Zhang, L. Z.; Du, G. H.; Qin, X. M. Anti-depressant Effects of Xiaoyaosan on Rat Model of Chronic Unpredictable Mild Stress: A Plasma Metabonomics Study Based on NMR Spectroscopy. J. Pharm. Pharmacol. 2012, 64, 578–584. DOI: 10.1111/j.2042-7158.2011.01412.x.
   PubMed Web of Science ®Google Scholar
• Javadi-Paydar, M.; Ghiassy, B.; Ebadian, S.; Rahimi, N.; Norouzi, A.; Dehpour, A. R. Nitric Oxide Mediates the Beneficial Effect of Chronic Naltrexone on Cholestasis-induced Memory Impairment in Male Rats. Behav. Pharmacol. 2013, 24, 195–206. DOI: 10.1097/FBP.0b013e3283618a8c.
   PubMed Web of Science ®Google Scholar
• Aghaei, I.; Shabani, M.; Doustar, N.; Nazeri, M.; Dehpour, A. Peroxisome Proliferator-activated Receptor-gamma Activation Attenuates Motor and Cognition Impairments Induced by Bile Duct Ligation in a Rat Model of Hepatic Cirrhosis. Pharmacol. Biochem. Behav. 2014, 120, 133–139. DOI: 10.1016/j.pbb.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Uchinami, H.; Seki, E.; Brenner, D. A.; D'Armiento, J. Loss of MMP 13 Attenuates Murine Hepatic Injury and Fibrosis during Cholestasis. Hepatology. 2006, 44, 420–429.
   PubMed Web of Science ®Google Scholar
• Tabet, E.; Genet, V.; Tiaho, F.; Lucas-Clerc, C.; Gelu-Simeon, M.; Piquet-Pellorce, C.; Samson, M. Chlordecone Potentiates Hepatic Fibrosis in Chronic Liver Injury Induced by Carbon Tetrachloride in Mice. Toxicol. Lett. 2016, 255, 1–10. DOI: 10.1016/j.toxlet.2016.02.005.
   PubMed Web of Science ®Google Scholar
• Huang, Y. T.; Hsu, Y. C.; Chen, C. J.; Liu, C. T.; Wei, Y. H. Oxidative-stress-related Changes in the Livers of Bile-duct-ligated Rats. J. Biomed. Sci. 2003, 10, 170–178. DOI: 10.1159/000068715.
   PubMed Web of Science ®Google Scholar
• Ferolla, S. M.; Armiliato, G. N.; Couto, C. A.; Ferrari, T. C. The Role of Intestinal Bacteria Overgrowth in Obesity-related Nonalcoholic Fatty Liver Disease. Nutrients. 2014, 6, 5583–5599. DOI: 10.3390/nu6125583.
   PubMed Web of Science ®Google Scholar
• Giannelli, V.; Di Gregorio V.; Iebba, V.; Giusto, M.; Schippa, S.; Merli, M.; Thalheimer, U. Microbiota and the Gut-liver Axis: Bacterial Translocation, Inflammation and Infection in Cirrhosis. WJG. 2014, 20, 16795–16810. DOI: 10.3748/wjg.v20.i45.16795.
   PubMed Web of Science ®Google Scholar
• Bradbury, M. J.; Campbell, U.; Giracello, D.; Chapman, D.; King, C.; Tehrani, L. Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice. J. Pharmacol. Exp. Ther. 2004, 313, 395–402. DOI: 10.1124/jpet.104.076406.
   PubMed Web of Science ®Google Scholar
• Haussinger, D.; Sies, H.; Gerok, W. Functional Hepatocyte Heterogeneity in Ammonia Metabolism. The Intercellular Glutamine Cycle. J. Hepatol 1985, 1, 3–14. DOI: 10.1016/S0168-8278(85)80063-5.
   PubMed Web of Science ®Google Scholar
• Lesniak, W. G.; Jyoti, A.; Mishra, M. K.; Louissaint, N.; Romero, R.; Chugani, D. C.; Kannan, S.; Kannan, R. M. Concurrent Quantification of Tryptophan and Its Major Metabolites. Anal. Biochem. 2013, 443, 222–231. DOI: 10.1002/hep.21268.
   PubMed Web of Science ®Google Scholar
• Rafice, S. A.; Chauhan, N.; Efimov, I.; Basran, J.; Raven, E. L. Oxidation of l-tryptophan in Biology: A Comparison Between Tryptophan 2,3-dioxygenase and Indoleamine 2,3-Dioxygenase. Biochm. Soc. Trans. 2009, 37, 408–412. DOI: 10.1042/BST0370408.
   PubMed Web of Science ®Google Scholar
• Maddison, D. C.; Giorgini, F. The Kynurenine Pathway and Neurodegenerative Disease. Semin. Cell Dev. Biol. 2015, 40, 134–141. DOI: 10.1016/j.semcdb.2015.03.002.
   PubMed Web of Science ®Google Scholar
• Mellor, A. L.; Munn, D. H. IDO Expression by Dendritic Cells: Tolerance and Tryptophan Catabolism. Nat. Rev. Immunol. 2004, 4, 762–774. DOI: 10.1038/nri1457.
   PubMed Web of Science ®Google Scholar
• Nagano, J.; Shimizu, M.; Hara, T.; Shirakami, Y.; Kochi, T.; Nakamura, N.; Ohtaki, H.; Ito, H.; Tanaka, T.; Tsurumi, H.; et al. Effects of Indoleamine 2,3-Dioxygenase Deficiency on High-fat Diet-induced Hepatic Inflammation. PLOS One 2013, 8, e73404. DOI: 10.1371/journal.pone.0073404.
   PubMed Web of Science ®Google Scholar
• Larrea, E.; Riezu-Boj, J. I.; Gil-Guerrero, L.; Casares, N.; Aldabe, R.; Sarobe, P.; Civeira, M. P.; Heeney, J. L.; Rollier, C.; Verstrepen, B.; et al. Upregulation of Indoleamine 2,3-dioxygenase in Hepatitis C Virus Infection. J. Virol. 2007, 81, 3662–3666. DOI: 10.1128/JVI.02248-06.
   PubMed Web of Science ®Google Scholar
• Higashitani, K.; Kanto, T.; Kuroda, S.; Yoshio, S.; Matsubara, T.; Kakita, N.; Oze, T.; Miyazaki, M.; Sakakibara, M.; Hiramatsu, N.; et al. Association of Enhanced Activity of Indoleamine 2,3-dioxygenase in Dendritic Cells with the Induction of Regulatory T Cells in Chronic Hepatitis C Infection. J. Gastroenterol. 2013, 48, 660–670. DOI: 10.1007/s00535-012-0667-z.
   PubMed Web of Science ®Google Scholar
• Banks, M. A.; Porter, D. W.; Martin, W. G.; Castranova, V. Ozone-induced Lipid Peroxidation and Membrane Leakage in Isolated Rat Alveolar Macrophages: Protective Effects of Taurine. J. Nutr. Biochem. 1991, 2, 308–313. DOI: 10.1016/0955-2863(91)90072-D.
   Web of Science ®Google Scholar
• Bhavsar, T. M.; Cantor, J. O.; Patel, S. N.; Lau-Cam, C. A. Attenuating Effect of Taurine on Lipopolysaccharide-induced Acute Lung Injury in Hamsters. Pharmacol. Res 2009, 60, 418–428. DOI: 10.1016/j.phrs.2009.05.006.
   PubMed Web of Science ®Google Scholar
• Huxtable, R. J. Physiological Actions of Taurine. Physiol. Rev. 1992, 72, 101–163. DOI: 10.1152/physrev.1992.72.1.101.
   PubMed Web of Science ®Google Scholar
• Ljubuncic, P.; Tanne, Z.; Bomzon, A. Evidence of a Systemic Phenomenon for Oxidative Stress in Cholestatic Liver Disease. Gut. 2000, 47, 710–716. DOI: 10.1136/gut.47.5.710.
   PubMed Web of Science ®Google Scholar
• Ovey, I. S.; Naziroglu, M. Homocysteine and Cytosolic GSH Depletion Induced Aproptosis and Oxidative Toxicity through Cytosolic Calcium Overload in the Hippocampus of Aged Mice: involvement of Trpm2 and Trpv1 Channels. Neuroscience. 2015, 284, 225–233. DOI: 10.1016/j.neuroscience.2014.09.078.
   PubMed Web of Science ®Google Scholar
• Landel, A. M.; Hammond, W. G.; Meguid, M. M. Aspects of Amino Acid and Protein Metabolism in Cancer-bearing States. Cancer. 1985, 55, 230–237. DOI: 10.1002/1097-0142(19850101)55:1+<230::AIDCNCR2820551305>3.0.CO;2-I.
   PubMed Web of Science ®Google Scholar
• Holecek, M. Three Targets of Branched-chain Amino Acid Supplementation in the Treatment of Liver Disease. Nutrition. 2010, 26, 482–490. DOI: 10.1016/j.nut.2009.06.027.
   PubMed Web of Science ®Google Scholar
• Nakanishi, C.; Doi, H.; Katsura, K.; Satomi, S. Treatment with L-Valine Ameliorates Liver Fibrosis and Restores Thrombopoiesis in Rats Exposed to Carbon Tetrachloride. Tohoku J. Exp. Med. 2010, 221, 151–159. DOI: 10.1620/tjem.221.151.
   PubMed Web of Science ®Google Scholar
• Lake, A. D.; Novak, P.; Shipkova, P.; Aranibar, N.; Robertson, D. G.; Reily, M. D.; Lehman-McKeeman, L. D.; Vaillancourt, R. R.; Cherrington, N. J. Branched Chain Amino Acid Metabolism Profiles in Progressive Human Nonalcoholic Fatty Liver Disease. Amino Acids. 2015, 47, 603–615. DOI: 10.1007/s00726-014-1894-9.
   PubMed Web of Science ®Google Scholar
• Williams, R.; Lock, E. Sodium Benzoate Attenuates D-serine Induced Nephrotoxicity in the Rat. Toxicology. 2005, 207, 35–48. DOI: 10.1016/j.tox.2004.08.008.
   PubMed Web of Science ®Google Scholar
• Bradford, B. U.; O'Connell, T. M.; Han, J.; Kosyk, O.; Shymonyak, S.; Ross, P. K.; Winnike, J.; Kono, H.; Rusyn, I. Metabolomic Profiling of a Modified Alcohol Liquid Diet Model for Liver Injury in the Mouse Uncovers New Markers of Disease. Toxicol. Appl. Pharmacol. 2008, 232, 236–243. DOI: 10.1016/j.taap.2008.06.022.
   PubMed Web of Science ®Google Scholar
• O’Connell, T. M. The Complex Role of Branched Chain Amino Acids in Diabetes and Cancer. Metabolites 2013, 3, 931–945. DOI: 10.3390/metabo3040931.
   PubMedGoogle Scholar
• Gao, R.; Cheng, J. H.; Fan, C. L.; Shi, X. F.; Cao, Y.; Sun, B.; Ding, H. G.; Hu, C. J.; Dong, F. T.; Yan, X. Z. Serum Metabolomics to Identify the Liver Disease-specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma. Sci. Rep. 2015, 5, 18175. DOI: 10.1038/srep18175.
   PubMed Web of Science ®Google Scholar
• Ranjbar, M. R. N.; Luo, Y.; Di Poto, C.; Varghese, R.; Ferrarini, A.; Zhang, C.; Sarhan, N. I.; Soliman, H.; Tadesse, M. G.; Ziada, D. H.; et al. GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort. PLoS One 2014, 10, e0127299. DOI: 10.1371/journal.pone.0127299.
   Web of Science ®Google Scholar
• Le, A.; Lane, A. N.; Hamaker, M.; Bose, S.; Gouw, A.; Barbi, J.; Tsukamoto, T.; Rojas, C. J.; Slusher, B. S.; Zhang, H. X.; et al. Glucose Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells. Cell Metab. 2012, 15, 110–121. DOI: 10.1016/j.cmet.2011.12.009.
   PubMed Web of Science ®Google Scholar
• Kakazu, E.; Kondo, Y.; Kogure, T.; Ninomiya, M.; Kimura, O.; Ueno, Y.; Shimosegawa, T. Plasma Amino Acids Imbalance in Cirrhotic Patients Disturbs the Tricarboxylic Acid Cycle of Dendritic Cell. Sci. Rep. 2013, 3, 3459. DOI: 10.1038/srep03459.
   PubMed Web of Science ®Google Scholar
• Stachowska, E.; Maciejewska, D.; Ossowski, P.; Drozd, A.; Ryterska, K.; Banaszczak, M.; Milkiewicz, M.; Raszeja-Wyszomirska, J.; Slebioda, M.; Milkiewicz, P. et al. Apolipoprotein E4 Allele Is Associated with Substantial Changes in the Plasma Lipids and Hyaluronic Acid Content in Patients with Nonalcoholic Fatty Liver Disease. J. Physiol. Pharmacol. 2013, 64, 711–717.
   PubMed Web of Science ®Google Scholar
• Guilbault, C.; Wojewodka, G.; Saeed, Z.; Hajduch, M.; Matouk, E.; De Sanctis, J. B.; Radzioch, D. Cystic Fibrosis Fatty Acid Imbalance Is Linked to Ceramide Deficiency and Corrected by Fenretinide. Am. Am. J. Respir. Cell Mol. Biol. 2009, 41, 100–106. DOI: 10.1165/rcmb.2008-0279OC.
   PubMed Web of Science ®Google Scholar
• Beyoğlu, D.; Imbeaud, S.; Maurhofer, O.; Bioulac-Sage, P.; Zucman-Rossi, J.; Dufour, J. F.; Idle, J. R. Tissue Metabolomics of Hepatocellular Carcinoma: Tumor Energy Metabolism and the Role of Transcriptomic Classification. Hepatology. 2013, 58, 229–238. DOI: 10.1002/hep.26350.
   PubMed Web of Science ®Google Scholar
• Geraci, J. P.; Mariano, M. S. Radiation Hepatology of the Rat: Association of the Production of Prostacyclin with Radiation-induced Hepatic Fibrosis. Radiat. Res. 1996, 145, 93–97. DOI: 10.2307/3579201.
   PubMed Web of Science ®Google Scholar
• Ishihara, K.; Miyazaki, A.; Nabe, T.; Fushimi, H.; Iriyama, N.; Kanai, S.; Sato, T.; Uozumi, N.; Shimizu, T.; Akiba, S. Group IVA Phospholipase A(2) Participates in the Progression of Hepatic Fibrosis. Faseb J. 2012, 26, 4111–4121. DOI: 10.1096/fj.12-205625.
   PubMed Web of Science ®Google Scholar
• He, J.; Wang, C.; Zhu, Y.; Ai, D. Soluble Epoxide Hydrolase: A Potential Target for Metabolic Diseases. J. Diabetes. 2016, 8, 305–313. DOI: 10.1111/1753-0407.12358.
   PubMed Web of Science ®Google Scholar
• Brouwers, J. F. H. M.; Vernooji, E. A. A. M.; Tielens, A. G. M.; van, G.,L. M. G. Rapid Separation and Identification of Phosphatidylethanolamine Molecular Species. J. Lipid Res. 1999, 40, 164–169.
   PubMed Web of Science ®Google Scholar
• Wright, M. M.; Howe, A. G.; Zaremberg, V. Cell Membranes and Apoptosis: Role of Cardiolipin, Phosphatidylcholine, and Anticancer Lipid Analogues. Biochem. Cell Biol. 2004, 82, 18–26. DOI: 10.1139/o03-092.
   PubMedGoogle Scholar
• Wolf, C.; Quinn, P. J. Lipidomics: Practical Aspects and Applications. Prog. Lipid Res. 2008, 47, 15–36. DOI: 10.1016/j.plipres.2007.09.001.
   PubMed Web of Science ®Google Scholar
• Sanyal, A. J.; Pacana, T. A Lipidomic Readout of Disease Progression in a Diet-induced Mouse Model of Nonalcoholic Fatty Liver Disease. T. Am. Clin. Climato. Assoc. 2015, 126, 271–288.
   PubMedGoogle Scholar
• Vance, D. E.; Ridgway, N. D. The Methylation of Phosphatidylethanolamine. Prog. Lipid Res. 1988, 27, 61–79.
   PubMed Web of Science ®Google Scholar
• DeLong, C. J.; Shen, Y. J.; Thomas, M. J.; Cui, Z. Molecular Distinction of Phosphatidylcholine Synthesis between the CDP-choline Pathway and Phosphatidylethanolamine Methylation Pathway. J. Biol. Chem. 1999, 274, 29683–29688. DOI: 10.1074/jbc.274.42.29683.
   PubMed Web of Science ®Google Scholar
• Vance, D. E. Role of Phosphatidylcholine Biosynthesis in the Regulation of Lipoprotein Homeostasis. Curr. Opin. Lipidol. 2008, 19, 229–234. DOI: 10.1097/MOL.0b013e3282fee935.
   PubMed Web of Science ®Google Scholar
• van der Veen, J. N.; Lingrell, S.; Gao, X. Pioglitazone Attenuates Hepatic Inflammation and Fibrosis in Phosphatidylethanolamine N-methyltransferase-deficient Mice. Am. J. Physiol-Gastr. L. 2016, 310, G526–G538. DOI: 10.1152/ajpgi.00243.2015.
   PubMed Web of Science ®Google Scholar
• Yin, P. Y.; Wan, D. F.; Zhao, C. X.; Chen, J.; Zhao, X. J.; Wang, W. Z.; Lu, X.; Yang, S. L.; Gu, J. R.; Xu, G. W. A Metabonomic Study of Hepatitis B-induced Liver Cirrhosis and Hepatocellular Carcinoma by Using RP-LC and HILIC Coupled with Mass Spectrometry. Mol. Biosyst. 2009, 5, 868–876. DOI: 10.1039/b820224a.
   PubMed Web of Science ®Google Scholar